Market Overview:
The global eye allergy therapeutics market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of eye allergies, rising awareness about available treatment options, and the launch of novel therapies. Based on type, the global eye allergy therapeutics market is segmented into antihistamines, corticosteroids, immunomodulators, and others. The antihistamines segment is expected to account for the largest share of the global eye allergy therapeutics market in 2018. This segment is also projected to grow at a CAGR of 5.9% during the forecast period from 2018 to 2030. This growth can be attributed to factors such as rising awareness about available treatment options and growing demand for over-the-counter (OTC) drugs for treating allergies. Based on application, the global eye allergy therapeutics market is divided into hospital pharmacies, retail pharmacies/drugstores, and other applications segments such as clinics/physicians’ offices and home care settings). The hospital pharmacies segment accounted for majority share (64%) of total revenue generated by all application segments in 2017; however this segment is projected witness a decline in its share by 2030 owing declining number patients visits due high cost treatments . On contrary , other application segments are anticipated register highest CAGR over next decade owing increase patient preference shifting towards self-care treatments .
Product Definition:
Eye allergy therapeutics are treatments used to manage eye allergies. Eye allergies are a common problem, and can cause symptoms such as red eyes, itchy eyes, and watery eyes. There are a number of different types of eye allergy therapies available, including over-the-counter medications and prescription medications.
Antihistamines:
Antihistamines are used to treat itching and inflammation caused by histamine. They work by blocking the action of histamine which is released during an allergic response. The most commonly used antihistamines are Loratadine (Claritin), fexofenadine (Allerga), diphenhydramine (Benadryl).
Global Antihistamines, it's usage.
Corticosteroids:
Corticosteroids are a group of anti-inflammatory drugs that act as immunosuppressants. They are used to reduce inflammation and itching by suppressing the release of cytokines (chemical messengers) in the brain and spinal cord.
Application Insights:
The other application segment held the largest share of over 70.0% in 2017. Other applications include environmental, cosmetic and pharmaceutical industries. The demand for anti-allergy drugs is expected to grow with the growing population as well as increasing number of allergy patients due to indoor pollution and climate change-induced changes in vegetation around the world, which will promote new product launches in this segment over the forecast period.
The hospital segment is anticipated to witness lucrative growth owing to a rise in prevalence of allergic diseases such as asthma and rhinitis among children along with an increase in number of surgeries being performed on an annual basis for these disorders globally since past few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high prevalence of eye allergies are some factors responsible for its large share. According to the National Institute of Health (NIH), around 25% to 35% of adults in U.S. suffer from allergic disorders such as hay fever or asthma that affect the eyes causing itchy, watery eyes or conjunctivitis occasionally or frequently.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing disposable income and awareness about various treatment options available for eye allergies among patients coupled with rising number of product launches by key companies operating within this region Such as GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; Allergan PLC; Sanofi SA; Unilever NV and Abbott Laboratories, Inc.
Growth Factors:
- Increasing prevalence of eye allergies
- Growing awareness about the treatment and management of eye allergies
- Rising demand for better and more effective therapies for the treatment of eye allergies
- Technological advancements in the field of ophthalmology that are helping to improve diagnosis and treatment options for eye allergies 5. increasing research funding towards development of new therapies for eye allergy
Scope Of The Report
Report Attributes
Report Details
Report Title
Eye Allergy Therapeutics Market Research Report
By Type
Antihistamines, Corticosteroids, Immunomodulators,
By Application
Hospital, Pharmacy, Other,
By Companies
Akorn, Allergan, Bausch Health, Novartis, Santen Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Eye Allergy Therapeutics Market Report Segments:
The global Eye Allergy Therapeutics market is segmented on the basis of:
Types
Antihistamines, Corticosteroids, Immunomodulators,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Akorn
- Allergan
- Bausch Health
- Novartis
- Santen Pharmaceutical
Highlights of The Eye Allergy Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Corticosteroids
- Immunomodulators
- By Application:
- Hospital
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Eye Allergy Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the key players operating in the eye allergy therapeutics market are Akorn, Allergan, Bausch Health, Novartis, Santen Pharmaceutical.
The eye allergy therapeutics market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Eye Allergy Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Eye Allergy Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Eye Allergy Therapeutics Market - Supply Chain
4.5. Global Eye Allergy Therapeutics Market Forecast
4.5.1. Eye Allergy Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Eye Allergy Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Eye Allergy Therapeutics Market Absolute $ Opportunity
5. Global Eye Allergy Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Eye Allergy Therapeutics Market Size and Volume Forecast by Type
5.3.1. Antihistamines
5.3.2. Corticosteroids
5.3.3. Immunomodulators
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Eye Allergy Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Eye Allergy Therapeutics Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Pharmacy
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Eye Allergy Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Eye Allergy Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Eye Allergy Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Eye Allergy Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Eye Allergy Therapeutics Demand Share Forecast, 2019-2026
9. North America Eye Allergy Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Eye Allergy Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Eye Allergy Therapeutics Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Pharmacy
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Eye Allergy Therapeutics Market Size and Volume Forecast by Type
9.7.1. Antihistamines
9.7.2. Corticosteroids
9.7.3. Immunomodulators
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Eye Allergy Therapeutics Demand Share Forecast, 2019-2026
10. Latin America Eye Allergy Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Eye Allergy Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Eye Allergy Therapeutics Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Pharmacy
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Eye Allergy Therapeutics Market Size and Volume Forecast by Type
10.7.1. Antihistamines
10.7.2. Corticosteroids
10.7.3. Immunomodulators
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Eye Allergy Therapeutics Demand Share Forecast, 2019-2026
11. Europe Eye Allergy Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Eye Allergy Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Eye Allergy Therapeutics Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Pharmacy
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Eye Allergy Therapeutics Market Size and Volume Forecast by Type
11.7.1. Antihistamines
11.7.2. Corticosteroids
11.7.3. Immunomodulators
11.8. Basis Point Share (BPS) Analysis y Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Eye Allergy Therapeutics Demand Share, 2019-2026
12. Asia Pacific Eye Allergy Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Eye Allergy Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Eye Allergy Therapeutics Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Pharmacy
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Eye Allergy Therapeutics Market Size and Volume Forecast by Type
12.7.1. Antihistamines
12.7.2. Corticosteroids
12.7.3. Immunomodulators
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Eye Allergy Therapeutics Demand Share, 2019-2026
13. Middle East & Africa Eye Allergy Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Eye Allergy Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Eye Allergy Therapeutics Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Pharmacy
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Eye Allergy Therapeutics Market Size and Volume Forecast by Type
13.7.1. Antihistamines
13.7.2. Corticosteroids
13.7.3. Immunomodulators
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Eye Allergy Therapeutics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Eye Allergy Therapeutics Market: Market Share Analysis
14.2. Eye Allergy Therapeutics Distributors and Customers
14.3. Eye Allergy Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Akorn
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Allergan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bausch Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santen Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
